Ignite Creation Date:
2024-05-06 @ 3:29 AM
Last Modification Date:
2024-10-26 @ 11:34 AM
Study NCT ID:
NCT02304406
Status:
COMPLETED
Last Update Posted:
2019-07-19
First Post:
2014-11-14
Brief Title:
Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East North Africa
Sponsor:
Organization:
Pfizer
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
The tissue samples of NSCLC cases will be retrieved from tissue banks of the molecular diagnostic units pathology departments in these study centers The histological diagnosis will be confirmed by the pathologists The retained samples will then be tested by performing the Ventana ALK-IHC to assess the absence or presence of the ALK rearrangement by the detection of the ALK protein in formalin-fixed paraffin-embedded NSCLC stored tissue samples using Ventana anti-ALK D5F3 Rabbit Monoclonal Primary Antibody Roche Diagnostics GmbH in the selected study centers
Enrollment Count:
449
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Other |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 28009 |
Who Masked List: